Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
65–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must give written informed consent before any assessment is performed
Patients with essential hypertension, untreated or currently taking antihypertensive therapy must have a mean sitting systolic blood pressure ≥ 150 mmHg and \< 180 mmHg
Patients must be able to communicate and comply with all study requirements and demonstrate good medication compliance
You may not be if
Patients with severe hypertension (msDBP ≥ 110 mmHg and/or msSBP ≥180 mmHg). Patients with history of angioedema, drug-related or otherwise
Patients with history or evidence of a secondary form of hypertension
Transient ischemic cerebral attack (TIA) during the 12 months prior to Visit 1 or any history of stroke
History of myocardial infarction, coronary bypass surgery or any percutaneous coronary intervention (PCI) during the 12 months prior to Visit 1.
Current angina pectoris requiring medication (other than patients on a stable dose of oral or topical nitrates).
Patients with Type 1 or Type 2 diabetes mellitus who are not well controlled and are not on a stable dose of antidiabetic medication
Patients with previous or current diagnosis of heart failure (NYHA Class II-IV).
Patients with a clinically significant valvular heart disease at the time of screening
